{"DataElement":{"publicId":"3395782","version":"1","preferredName":"Sulindac Dispensed Last Visit Pill Dosage Form Number","preferredDefinition":"Total number of Sulindac/placebo pills dispensed to the patient.","longName":"3395778v1.0:2018762v1.0","context":"SWOG","contextVersion":"1","DataElementConcept":{"publicId":"3395778","version":"1","preferredName":"Sulindac Dispensed Last Visit","preferredDefinition":"Sulindac/placebo pills dispensed to the patient.","longName":"3395776v1.0:2207913v1.0","context":"SWOG","contextVersion":"1","ObjectClass":{"publicId":"3395776","version":"1","preferredName":"Sulindac Dispensed Amount","preferredDefinition":"A sulfinylindene derivative prodrug with potential antineoplastic activity. Converted in vivo to an active metabolite, sulindac, a nonsteroidal anti-inflammatory drug (NSAID), blocks cyclic guanosine monophosphate-phosphodiesterase (cGMP-PDE), an enzyme that inhibits the normal apoptosis signal pathway; this inhibition permits the apoptotic signal pathway to proceed unopposed, resulting in apoptotic cell death. (NCI04):The quantity of a product that has been dispensed.","longName":"C850:C78721","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sulindac","conceptCode":"C850","definition":"A sulfinylindene derivative prodrug with potential antineoplastic activity. Converted in vivo to an active metabolite, sulindac, a nonsteroidal anti-inflammatory drug (NSAID), blocks cyclic guanosine monophosphate-phosphodiesterase (cGMP-PDE), an enzyme that inhibits the normal apoptosis signal pathway; this inhibition permits the apoptotic signal pathway to proceed unopposed, resulting in apoptotic cell death. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dispensed Amount","conceptCode":"C78721","definition":"The quantity of a product that has been dispensed.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA228405-D3A3-608B-E040-BB89AD432912","latestVersionIndicator":"Yes","beginDate":"2012-02-29","endDate":null,"createdBy":"SMITHA","dateCreated":"2012-02-29","modifiedBy":"ONEDATA","dateModified":"2012-02-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207913","version":"1","preferredName":"Last Visit","preferredDefinition":"Coming after all others in time or space or degree or being the only one remaining.:the act of going to see some person or place or thing for a short time.","longName":"C25551:CL052808","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Last","conceptCode":"C25551","definition":"Coming after all others in time or space or degree or being the only one remaining.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Visit","conceptCode":"CL052808","definition":"the act of going to see some person or place or thing for a short time.","evsSource":"NCI_META_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-34D7-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA228405-D3B1-608B-E040-BB89AD432912","latestVersionIndicator":"Yes","beginDate":"2012-02-29","endDate":null,"createdBy":"SMITHA","dateCreated":"2012-02-29","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"5/16/13 jc moved to SWOG context.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018762","version":"1","preferredName":"Pill Dosage Form Number","preferredDefinition":"Numeric value for amount of pills.","longName":"NR_PILLS","context":"SPOREs","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2720394","version":"1","preferredName":"Pills Number","preferredDefinition":"A dose of medicine in the form of a small pellet.:Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.","longName":"C25394:C25337","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pill Dosage Form","conceptCode":"C25394","definition":"A solid composed of a small, round object composed of active and/or inert ingredient(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"43BBB83C-99CB-2B51-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-01-15","modifiedBy":"ONEDATA","dateModified":"2008-01-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7FB10A7-364B-2271-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-03","endDate":"2008-01-14","createdBy":"MEDVEDOH","dateCreated":"2003-03-03","modifiedBy":"REEVESD","dateModified":"2008-01-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Number of sulindac/placebo pi","type":"Preferred Question Text","description":"Number of sulindac/placebo pills dispensed at resupply","url":null,"context":"SWOG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA228405-D3E7-608B-E040-BB89AD432912","latestVersionIndicator":"Yes","beginDate":"2012-02-29","endDate":null,"createdBy":"SMITHA","dateCreated":"2012-02-29","modifiedBy":"SCOTTM","dateModified":"2013-11-07","changeDescription":"5/16/13 jc moved to SWOG context.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}